Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Rltpr Is a Central Scaffold Protein Regulating Human TCR Co-Signaling and Cytoskeletal Dynamics

Tilmann Schober, MD, Thomas Magg, PhD, Melanie Laschinger, PhD, Thomas Fröhlich, PhD, Meino Rohlfs, PhD, Yanshan Liu, PhD, Jacek Puchalka, PhD, Tanja Weisser, Karin Fehlner, PhD, Christoph Walz, MD, Natália Duarte Linhares, PhD, Sérgio D. Pena, MD PhD, Bernd H. Belohradsky, MD, Christoph Klein, MD PhD, Fabian Hauck, MD PhD

Blood (2016) 128 (22): 131.

https://doi.org/10.1182/blood.V128.22.131.131

Published: 2016

Journal Articles

A Human Bone Marrow Failure Syndrome Caused By a Homozygous Mutation in MYSM1

Ehsan Bahrami, Tomas Racek, PhD, Maximilian Witzel, MD, Jacek Puchalka, PhD, Naschla Greif-Kohistani, MD, Daniel Kotlarz, MD PhD, Michael Orth, PhD, Kirsten Lauber, PhD, Christoph Walz, MD, Waleed Al Herz, MD, Hans-Peter Horny, MD, Heinrich Schmidt, MD, Michael H. Albert, MD, Christoph Klein, MD PhD

Blood (2015) 126 (23): 1204.

https://doi.org/10.1182/blood.V126.23.1204.1204

Published: 2015

Journal Articles

Molecular Profiling of Myeloid Progenitor Cells in Multi-Mutated Advanced Systemic Mastocytosis Identifies KIT D816V As a Distinct and Late Event

Mohamad Jawhar, MD, Juliana Schwaab, MD, Susanne Schnittger, PhD, Karl Sotlar, MD, Hans Peter Horny, MD, Georgia Metzgeroth, Sven Schneider, MD, Nadine Müller, Nicole Naumann, Christoph Walz, MD, Torsten Haferlach, Peter Valent, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Alice Fabarius, PhD, Andreas Reiter, MD

Blood (2014) 124 (21): 3216.

https://doi.org/10.1182/blood.V124.21.3216.3216

Published: 2014

Journal Articles

KIT D816V and JAK2 V617F Point Mutations Are Recurrently Found In Suspected Hypereosinophilic Syndrome

Juliana Popa, MD, Philipp Erben, MD, Georgia Metzgeroth, MD, Georg Bolz, MD, Martin C Mueller, MD, Christoph Walz, MD, Hans Peter Horny, MD, Philipp Ströbel, MD, Alexander Marx, MD, Nicholas C.P. Cross, PhD, FRCPath, Andreas Hochhaus, Wolf-Karsten Hofmann, MD, Andreas Reiter, MD

Blood (2010) 116 (21): 4100.

https://doi.org/10.1182/blood.V116.21.4100.4100

Published: 2010

Journal Articles

Essential Role for Stat5a/b in Myeloproliferative Neoplasms Induced by BCR-ABL1 and Jak2 V617F.

Christoph Walz, MD, Katherine Lazarides, Nihal Patel, Lothar Hennighausen, PhD, Virginia M. Zaleskas, MD, Richard A. Van Etten, MD, PhD

Blood (2009) 114 (22): 312.

https://doi.org/10.1182/blood.V114.22.312.312

Published: 2009

Journal Articles

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Christian Elling, Philipp Erben, MD, Christoph Walz, MD, Marie Frickenhaus, Mirle Schemionek, PhD, Martin Stehling, PhD, Hubert Serve, MD, PhD, Nick C.P. Cross, PhD, Wolfgang Berdel, MD, Carsten Mueller-Tidow, MD, Andreas Reiter, MD, Steffen Koschmieder, MD

Blood (2009) 114 (22): 767.

https://doi.org/10.1182/blood.V114.22.767.767

Published: 2009

Journal Articles

Novel Transforming Mutations of CBL in Human Acute Myeloid Leukemia

Margret S Rodrigues, PhD, Mamatha M Reddy, Christoph Walz, MD, Ravi Salgia, Klaus Podar, Hamid Band, Andreas Reiter, MD, James D Griffin, Martin Sattler

Blood (2008) 112 (11): 2948.

https://doi.org/10.1182/blood.V112.11.2948.2948

Published: 2008

Journal Articles

Switch Pocket Inhibitors of the ABL Tyrosine Kinase: Distinct Kinome Inhibition Profiles and in Vivo Efficacy in Mouse Models of CML and B-Lymphoblastic Leukemia Induced by BCR-ABL T315I

Richard A. Van Etten, MD, PhD, Wayne W. Chan, BA, Virginia M. Zaleskas, MD, Christoph Walz, MD, Peter Evangelista, BA, Katherine Lazarides, BS, Monica Betancur, MS, Scott Wise, MS, Peter A. Petillo, PhD, Daniel L. Flynn, PhD

Blood (2008) 112 (11): 576.

https://doi.org/10.1182/blood.V112.11.576.576

Published: 2008

Journal Articles

Characterization of Three New Fusion Genes Generated by Disruption of PDGFRB in Eosinophilia-Associated Chronic Myeloproliferative Neoplasms

Philipp Erben, MD, Darko Gosenca, PhD, Christoph Walz, MD, Georgia Metzgeroth, MD, Claudia Haferlach, MD, Martin C. Müller, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Andreas Reiter, MD

Blood (2008) 112 (11): 3719.

https://doi.org/10.1182/blood.V112.11.3719.3719

Published: 2008

Journal Articles

Complete Hematologic Response to Sunitinib in an Eosinophilia-Associated Chronic Myeloproliferative Disorder with an ETV6-FLT3 Fusion Gene.

Christoph Walz, MD, Michael Ritter, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Christoph Schulte, MD, Torsten Haferlach, MD, PhD, Georgia Metzgeroth, MD, Rüdiger Hehlmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Andreas Reiter, MD

Blood (2007) 110 (11): 3558.

https://doi.org/10.1182/blood.V110.11.3558.3558

Published: 2007

Journal Articles

Association between Polymorphic Variation at the IL5RA Locus and the Severity of FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukaemia

Sonja Burgstaller, MD, Sebastian Kreil, MD, Katherine Waghorn, BSc, Georgia Metzgeroth, MD, Claude Preudhomme, PhD, Katerina Zoi, PhD, Helen White, PhD, Daniela Cilloni, PhD, Christine Zoi, MD, Finella Brito-Babapulle, MD, Christoph Walz, MD, Andreas Reiter, MD, Nicholas C.P. Cross, PhD

Blood (2007) 110 (11): 1544.

https://doi.org/10.1182/blood.V110.11.1544.1544

Published: 2007

Journal Articles

Diagnosis and Monitoring of Residual Disease by Quantitative RT-PCR in Eosinophilia-Associated Myeloproliferative Disorders with Rearrangements of PDGFRA and PDGFRB.

Philipp Erben, MD, Martin C. Mueller, MD, Georgia Metzgeroth, MD, Helena Popp, Christoph Walz, MD, Thomas Schenk, MD, Stephanie Lauber, MD, Jens Kruth, MD, Nicholas C.P. Cross, PhD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD, Andreas Reiter, MD

Blood (2006) 108 (11): 2690.

https://doi.org/10.1182/blood.V108.11.2690.2690

Published: 2006

Journal Articles

Characterization of Two New Imatinib-Responsive Fusion Genes Generated by Disruption of PDGFRB in Eosinophilia-Associated Chronic Myeloproliferative Disorders.

Christoph Walz, MD, Georgia Metzgeroth, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Andreas Reiter, MD

Blood (2006) 108 (11): 667.

https://doi.org/10.1182/blood.V108.11.667.667

Published: 2006

Journal Articles

A Phase-II-Study To Evaluate Efficacy and Safety of Imatinib in Eosinophilia-Associated Myeloproliferative Disorders and Idiopathic Hypereosinophilic Syndrome.

Georgia Metzgeroth, MD, Helena Popp, Christoph Walz, MD, Philipp Erben, MD, Jürgen Mix, Martin C. Müller, MD, Rüdiger Hehlmann, MD, Andreas Hochhaus, MD, Andreas Reiter, MD

Blood (2006) 108 (11): 671.

https://doi.org/10.1182/blood.V108.11.671.671

Published: 2006

NARROW

Rltpr Is a Central Scaffold Protein Regulating Human TCR Co-Signaling and Cytoskeletal Dynamics

A Human Bone Marrow Failure Syndrome Caused By a Homozygous Mutation in MYSM1

Molecular Profiling of Myeloid Progenitor Cells in Multi-Mutated Advanced Systemic Mastocytosis Identifies KIT D816V As a Distinct and Late Event

KIT D816V and JAK2 V617F Point Mutations Are Recurrently Found In Suspected Hypereosinophilic Syndrome

Essential Role for Stat5a/b in Myeloproliferative Neoplasms Induced by BCR-ABL1 and Jak2 V617F.

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Novel Transforming Mutations of CBL in Human Acute Myeloid Leukemia

Switch Pocket Inhibitors of the ABL Tyrosine Kinase: Distinct Kinome Inhibition Profiles and in Vivo Efficacy in Mouse Models of CML and B-Lymphoblastic Leukemia Induced by BCR-ABL T315I

Characterization of Three New Fusion Genes Generated by Disruption of PDGFRB in Eosinophilia-Associated Chronic Myeloproliferative Neoplasms

Complete Hematologic Response to Sunitinib in an Eosinophilia-Associated Chronic Myeloproliferative Disorder with an ETV6-FLT3 Fusion Gene.

Association between Polymorphic Variation at the IL5RA Locus and the Severity of FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukaemia

Diagnosis and Monitoring of Residual Disease by Quantitative RT-PCR in Eosinophilia-Associated Myeloproliferative Disorders with Rearrangements of PDGFRA and PDGFRB.

Characterization of Two New Imatinib-Responsive Fusion Genes Generated by Disruption of PDGFRB in Eosinophilia-Associated Chronic Myeloproliferative Disorders.

A Phase-II-Study To Evaluate Efficacy and Safety of Imatinib in Eosinophilia-Associated Myeloproliferative Disorders and Idiopathic Hypereosinophilic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only